Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myasthenia Gravis | 22 | 2023 | 217 | 8.850 |
Why?
|
Peripheral Nervous System Diseases | 5 | 2024 | 716 | 2.190 |
Why?
|
Immunologic Factors | 6 | 2021 | 1597 | 1.300 |
Why?
|
Myositis | 4 | 2020 | 269 | 1.250 |
Why?
|
Muscular Diseases | 4 | 2020 | 553 | 1.210 |
Why?
|
Neurotoxicity Syndromes | 2 | 2020 | 302 | 0.980 |
Why?
|
Receptors, Cholinergic | 6 | 2022 | 244 | 0.950 |
Why?
|
Paraneoplastic Syndromes, Nervous System | 2 | 2024 | 24 | 0.930 |
Why?
|
Neuromuscular Diseases | 2 | 2020 | 261 | 0.900 |
Why?
|
Lambert-Eaton Myasthenic Syndrome | 2 | 2020 | 8 | 0.870 |
Why?
|
Myotonia Congenita | 1 | 2020 | 16 | 0.740 |
Why?
|
Myotonic Dystrophy | 1 | 2020 | 80 | 0.700 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2022 | 667 | 0.680 |
Why?
|
Botulism | 1 | 2019 | 21 | 0.680 |
Why?
|
Genes, cdc | 1 | 2019 | 114 | 0.650 |
Why?
|
Histamine H1 Antagonists | 1 | 2019 | 101 | 0.650 |
Why?
|
Blepharoptosis | 1 | 2020 | 145 | 0.640 |
Why?
|
Ophthalmoplegia, Chronic Progressive External | 1 | 2018 | 17 | 0.630 |
Why?
|
Neural Conduction | 2 | 2020 | 443 | 0.600 |
Why?
|
Medical Order Entry Systems | 1 | 2023 | 523 | 0.580 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 98 | 0.560 |
Why?
|
Immunotherapy | 5 | 2021 | 4756 | 0.540 |
Why?
|
Pregnancy Complications | 3 | 2017 | 2974 | 0.540 |
Why?
|
Myocarditis | 2 | 2022 | 803 | 0.490 |
Why?
|
Physical Examination | 1 | 2021 | 1262 | 0.490 |
Why?
|
Antibodies | 2 | 2020 | 2422 | 0.480 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2015 | 37 | 0.470 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2231 | 0.470 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3118 | 0.450 |
Why?
|
Desensitization, Immunologic | 1 | 2019 | 558 | 0.450 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3241 | 0.450 |
Why?
|
Decision Support Systems, Clinical | 1 | 2023 | 1178 | 0.430 |
Why?
|
Immunosuppressive Agents | 4 | 2020 | 4207 | 0.430 |
Why?
|
Disease Management | 3 | 2020 | 2537 | 0.400 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1241 | 0.380 |
Why?
|
Nervous System Diseases | 2 | 2021 | 1665 | 0.380 |
Why?
|
Patient Education as Topic | 1 | 2021 | 2339 | 0.370 |
Why?
|
Peripheral Nerves | 1 | 2015 | 492 | 0.360 |
Why?
|
Drug Hypersensitivity | 1 | 2019 | 923 | 0.350 |
Why?
|
Deglutition Disorders | 3 | 2020 | 641 | 0.330 |
Why?
|
Recovery of Function | 1 | 2018 | 2990 | 0.300 |
Why?
|
Autoantibodies | 3 | 2024 | 2120 | 0.280 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7460 | 0.270 |
Why?
|
Telemedicine | 2 | 2021 | 3110 | 0.270 |
Why?
|
Physicians | 2 | 2021 | 4607 | 0.250 |
Why?
|
Electromyography | 2 | 2020 | 1401 | 0.250 |
Why?
|
Neoplasms | 7 | 2024 | 22389 | 0.240 |
Why?
|
Pain | 1 | 2019 | 5100 | 0.230 |
Why?
|
Humans | 44 | 2024 | 768970 | 0.230 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2020 | 1629 | 0.220 |
Why?
|
Melanoma | 2 | 2020 | 5709 | 0.210 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 154 | 0.200 |
Why?
|
Self Administration | 2 | 2020 | 386 | 0.200 |
Why?
|
Skin Neoplasms | 2 | 2020 | 5864 | 0.200 |
Why?
|
Phenotype | 1 | 2019 | 16731 | 0.190 |
Why?
|
Diplopia | 1 | 2022 | 217 | 0.180 |
Why?
|
Infusions, Subcutaneous | 1 | 2020 | 43 | 0.180 |
Why?
|
Neuromuscular Junction Diseases | 2 | 2019 | 14 | 0.170 |
Why?
|
Complement C5 | 1 | 2020 | 104 | 0.170 |
Why?
|
Complement Inactivating Agents | 1 | 2020 | 53 | 0.170 |
Why?
|
Electrodiagnosis | 1 | 2020 | 149 | 0.170 |
Why?
|
Pandemics | 4 | 2020 | 8749 | 0.170 |
Why?
|
Terfenadine | 1 | 2019 | 16 | 0.170 |
Why?
|
Paresthesia | 1 | 2020 | 160 | 0.170 |
Why?
|
Ice | 1 | 2020 | 102 | 0.170 |
Why?
|
Thymus Neoplasms | 1 | 2022 | 277 | 0.170 |
Why?
|
Chloride Channels | 1 | 2020 | 221 | 0.170 |
Why?
|
Diphenhydramine | 1 | 2019 | 63 | 0.160 |
Why?
|
Prednisone | 2 | 2021 | 1567 | 0.160 |
Why?
|
Macrolides | 1 | 2020 | 205 | 0.160 |
Why?
|
Premedication | 1 | 2019 | 246 | 0.160 |
Why?
|
Chloroquine | 1 | 2020 | 276 | 0.150 |
Why?
|
Guillain-Barre Syndrome | 1 | 2020 | 127 | 0.150 |
Why?
|
Urination Disorders | 1 | 2019 | 238 | 0.150 |
Why?
|
Pregnancy | 3 | 2017 | 30265 | 0.150 |
Why?
|
House Calls | 1 | 2020 | 171 | 0.150 |
Why?
|
Polyneuropathies | 1 | 2019 | 139 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11886 | 0.140 |
Why?
|
Fasciitis | 1 | 2018 | 66 | 0.140 |
Why?
|
Plasma Exchange | 2 | 2020 | 159 | 0.140 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 417 | 0.140 |
Why?
|
Medication Errors | 1 | 2023 | 785 | 0.140 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 371 | 0.130 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
Female | 20 | 2021 | 397515 | 0.130 |
Why?
|
4-Aminopyridine | 1 | 2015 | 81 | 0.130 |
Why?
|
Encephalitis | 1 | 2019 | 441 | 0.120 |
Why?
|
Orphan Drug Production | 1 | 2015 | 48 | 0.120 |
Why?
|
Acetaminophen | 1 | 2019 | 556 | 0.120 |
Why?
|
Potassium Channel Blockers | 1 | 2015 | 162 | 0.120 |
Why?
|
Viral Vaccines | 1 | 2020 | 596 | 0.120 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 843 | 0.120 |
Why?
|
Spinal Neoplasms | 1 | 2020 | 715 | 0.110 |
Why?
|
Patients | 1 | 2020 | 908 | 0.110 |
Why?
|
Registries | 2 | 2020 | 8384 | 0.110 |
Why?
|
Herpesvirus 4, Human | 1 | 2019 | 1082 | 0.110 |
Why?
|
Eosinophilia | 1 | 2018 | 556 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1119 | 0.110 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1134 | 0.110 |
Why?
|
Aged | 12 | 2021 | 171786 | 0.100 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2434 | 0.100 |
Why?
|
Disease Progression | 2 | 2020 | 13674 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 2 | 2019 | 1811 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2019 | 1378 | 0.100 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1359 | 0.100 |
Why?
|
Neurology | 1 | 2020 | 787 | 0.100 |
Why?
|
Male | 15 | 2021 | 365203 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1891 | 0.100 |
Why?
|
Research | 1 | 2020 | 1981 | 0.090 |
Why?
|
Hydrocortisone | 1 | 2019 | 1841 | 0.090 |
Why?
|
Consensus | 1 | 2021 | 3214 | 0.090 |
Why?
|
Spinal Cord | 1 | 2019 | 1813 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2020 | 1789 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1892 | 0.090 |
Why?
|
Adult | 9 | 2020 | 223851 | 0.090 |
Why?
|
Patient Care Team | 1 | 2021 | 2528 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2021 | 59739 | 0.080 |
Why?
|
Middle Aged | 13 | 2021 | 223737 | 0.080 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15951 | 0.080 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3726 | 0.080 |
Why?
|
Th1 Cells | 1 | 2013 | 1042 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2725 | 0.080 |
Why?
|
Kidney Diseases | 1 | 2019 | 2100 | 0.080 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5505 | 0.080 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1473 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2493 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2020 | 3070 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2019 | 4978 | 0.070 |
Why?
|
Th17 Cells | 1 | 2013 | 791 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2258 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4413 | 0.070 |
Why?
|
Muscle Weakness | 2 | 2019 | 413 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2021 | 81903 | 0.060 |
Why?
|
Ultrasonography | 2 | 2018 | 6002 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2023 | 4879 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3253 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2022 | 65480 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5375 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5956 | 0.050 |
Why?
|
Drug Resistance | 1 | 2017 | 1599 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2020 | 12467 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4651 | 0.040 |
Why?
|
Myoglobinuria | 1 | 2019 | 22 | 0.040 |
Why?
|
Adrenal Gland Diseases | 1 | 2020 | 141 | 0.040 |
Why?
|
Mastication | 1 | 2019 | 53 | 0.040 |
Why?
|
Urogenital Neoplasms | 1 | 2020 | 132 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7453 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 687 | 0.040 |
Why?
|
Rhabdomyolysis | 1 | 2019 | 150 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 30046 | 0.040 |
Why?
|
Carotid Artery, Internal | 1 | 2019 | 445 | 0.030 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2020 | 329 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2020 | 667 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 2019 | 975 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1836 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2018 | 1609 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13021 | 0.030 |
Why?
|
Eosinophils | 1 | 2018 | 953 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36854 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1794 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1434 | 0.030 |
Why?
|
Brain | 1 | 2019 | 27453 | 0.020 |
Why?
|
Vaccines | 1 | 2020 | 843 | 0.020 |
Why?
|
Hemolysis | 1 | 2012 | 417 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2569 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2013 | 1866 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2164 | 0.020 |
Why?
|
Cell Separation | 1 | 2013 | 1728 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8894 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8559 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2931 | 0.020 |
Why?
|
Anaphylaxis | 1 | 2012 | 758 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8055 | 0.010 |
Why?
|
Hypersensitivity | 1 | 2012 | 1173 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5906 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4568 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10847 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 89244 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 60131 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10633 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41808 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20776 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13594 | 0.010 |
Why?
|
United States | 1 | 2022 | 73186 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74976 | 0.010 |
Why?
|
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_